Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Prader-Willi Syndrome (PWS) - Overview
Prader-Willi Syndrome (PWS) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Prader-Willi Syndrome (PWS) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Prader-Willi Syndrome (PWS) - Companies Involved in Therapeutics Development

9 Meters Biopharma Inc
Aardvark Therapeutics Inc
Altamira Therapeutics Ltd
Benuvia Therapeutics Inc
Beryl Therapeutics Inc
Biomind Labs Inc
Bioprojet SCR
Carmot Therapeutics Inc
ConSynce Therapeutics Inc
Ferring Intertiol Center SA
GLWL Research Inc
Helsinn Group
Inversago Pharma Inc
Lipidio Pharmaceuticals Inc
Lumos Pharma Inc
Neuracle Science Co Ltd
Neuren Pharmaceuticals Ltd
Notitia Biotechnologies Co
OptiNose Inc
OT4B
Sanio AB
Soleno Therapeutics Inc
Taysha Gene Therapies Inc
Tonix Pharmaceuticals Holding Corp
Prader-Willi Syndrome (PWS) - Drug Profiles
(metoprolol + tesofensine) - Drug Profile
Product Description
Mechanism Of Action
History of Events
betahistine dihydrochloride - Drug Profile
Product Description
Mechanism Of Action
History of Events
Biologic for Prader Willi Syndrome - Drug Profile
Product Description
Mechanism Of Action
Bittera - Drug Profile
Product Description
Mechanism Of Action
BMND-04 - Drug Profile
Product Description
Mechanism Of Action
canbidiol - Drug Profile
Product Description
Mechanism Of Action
History of Events
carbetocin LA - Drug Profile
Product Description
Mechanism Of Action
History of Events
CSTI-500 - Drug Profile
Product Description
Mechanism Of Action
diazoxide choline CR - Drug Profile
Product Description
Mechanism Of Action
History of Events
GDD-3898 - Drug Profile
Product Description
Mechanism Of Action
GLWL-01 - Drug Profile
Product Description
Mechanism Of Action
History of Events
HM-04 - Drug Profile
Product Description
Mechanism Of Action
History of Events
HU-671 - Drug Profile
Product Description
Mechanism Of Action
ibutamoren mesylate - Drug Profile
Product Description
Mechanism Of Action
History of Events
INV-202 - Drug Profile
Product Description
Mechanism Of Action
History of Events
MRI-1867 - Drug Profile
Product Description
Mechanism Of Action
History of Events
NM-136 - Drug Profile
Product Description
Mechanism Of Action
History of Events
NNZ-2591 - Drug Profile
Product Description
Mechanism Of Action
History of Events
NS-200 - Drug Profile
Product Description
Mechanism Of Action
oxytocin - Drug Profile
Product Description
Mechanism Of Action
oxytocin - Drug Profile
Product Description
Mechanism Of Action
History of Events
oxytocin - Drug Profile
Product Description
Mechanism Of Action
History of Events
oxytocin - Drug Profile
Product Description
Mechanism Of Action
History of Events
pitolisant hydrochloride - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecule to Activate snRNP-N for Prader-Willi Syndrome - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Inhibit SMCHD1 for Prader Willi Syndrome - Drug Profile
Product Description
Mechanism Of Action
Synthetic Peptides to Target Incretin for Prader-Willi syndrome - Drug Profile
Product Description
Mechanism Of Action
History of Events
TSHA-116 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Prader-Willi Syndrome (PWS) - Dormant Projects
Prader-Willi Syndrome (PWS) - Discontinued Products
Prader-Willi Syndrome (PWS) - Product Development Milestones
Featured News & Press Releases
Mar 09, 2022: Running for research - Prader-Willi Syndrome to fund multi-center study of DCCR in early phase Prader-Willi syndrome
Mar 03, 2022: Tonix Pharmaceuticals announces FDA Orphan-Drug Desigtion for TNX-2900 for the treatment of Prader-Willi Syndrome
Feb 28, 2022: Tonix Pharmaceuticals announces research agreement with the French tiol Institute of Health and Medical Research (Inserm) to study the mechanism of oxytocin-mediated improvement of eating behaviors in Prader-Willi Mice
Feb 03, 2022: Aardvark starts enrolment in three Phase II trials of TAS2R agonist
Jan 24, 2022: Soleno Therapeutics provides regulatory update on DCCR for the treatment of Prader-Willi syndrome
Dec 28, 2021: Sanio initiates phase 2b clinical trial of tesomet for Prader-Willi syndrome
Oct 18, 2021: Sanio completes submission of manufacturing data for Tesomet capsules to U.S. FDA
Oct 11, 2021: US patent to 2034 granted for Neuren’s NNZ-2591 in autism
Sep 17, 2021: adMare Portfolio Company, Inversago Pharma initiates a phase 1 clinical trial on INV-202, a next generation peripherally-acting CB1 Blocker
Sep 08, 2021: Soleno Therapeutics announces positive data showing continued significant improvements in symptoms of PWS following one year treatment with DCCR
Sep 07, 2021: Inversago Pharma initiates a phase 1 clinical trial on INV-202, a next generation peripherally-acting CB1 blocker
Sep 03, 2021: FDA grants Orphan Drug Desigtion for NNZ-2591 to treat Prader-Willi syndrome
Jul 26, 2021: Sanio receives U.S. FDA orphan drug desigtion for Tesomet in hypothalamic obesity
Jul 22, 2021: Radius Health announces plans for global Prader-Willi syndrome pivotal study
Jul 06, 2021: Soleno Therapeutics provides regulatory update on DCCR for the treatment of Prader-Willi syndrome
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Prader-Willi Syndrome (PWS), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Prader-Willi Syndrome (PWS), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Prader-Willi Syndrome (PWS) - Pipeline by 9 Meters Biopharma Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Aardvark Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Altamira Therapeutics Ltd, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Benuvia Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Beryl Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Biomind Labs Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Bioprojet SCR, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Carmot Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by ConSynance Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Ferring International Center SA, 2022
Prader-Willi Syndrome (PWS) - Pipeline by GLWL Research Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Helsinn Group, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Inversago Pharma Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Lipidio Pharmaceuticals Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Lumos Pharma Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Neuracle Science Co Ltd, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Neuren Pharmaceuticals Ltd, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Notitia Biotechnologies Co, 2022
Prader-Willi Syndrome (PWS) - Pipeline by OptiNose Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by OT4B, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Saniona AB, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Soleno Therapeutics Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Taysha Gene Therapies Inc, 2022
Prader-Willi Syndrome (PWS) - Pipeline by Tonix Pharmaceuticals Holding Corp, 2022
Prader-Willi Syndrome (PWS) - Dormant Projects, 2022
Prader-Willi Syndrome (PWS) - Discontinued Products, 2022